---
title: "LFCR: Revenue and profit declined, but cost cuts and new wins support strong long-term growth outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294978843.md"
description: "Q2 revenue and profit declined year-over-year, but cost reductions and new business wins support reaffirmed 2026 guidance. Strong HA manufacturing and CDMO momentum, combined with industry tailwinds and operational improvements, position the company for mid- and long-term growth.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T13:56:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294978843.md)
  - [en](https://longbridge.com/en/news/294978843.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294978843.md)
generator: "portal-rs"
---

# LFCR: Revenue and profit declined, but cost cuts and new wins support strong long-term growth outlook

Q2 revenue and profit declined year-over-year, but cost reductions and new business wins support reaffirmed 2026 guidance. Strong HA manufacturing and CDMO momentum, combined with industry tailwinds and operational improvements, position the company for mid- and long-term growth.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [LFCR.US](https://longbridge.com/en/quote/LFCR.US.md)

## Related News & Research

- [LFCR: Revenue and profit declined, with liquidity sufficient but major preferred stock redemptions looming](https://longbridge.com/en/news/294961714.md)
- [LFCR: Q2 revenue fell 6.2% to $34.2M, but new business wins and guidance reaffirmed](https://longbridge.com/en/news/294961069.md)
- [Canal Ventures CEO Matsuoka spotlights SQUEEZE’s AI-led push to lift hotel productivity at BIPROGY Forum 2026](https://longbridge.com/en/news/296041975.md)
- [Genprex signs CDMO deal to scale up manufacturing for diabetes gene therapy program](https://longbridge.com/en/news/296218198.md)
- [1 Stock to Buy for the AI Revolution](https://longbridge.com/en/news/296027996.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**